Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit

Core Insights - Nexalin Technology, Inc. is participating in the 2025 Maxim Growth Summit on October 22nd, showcasing its leadership in Deep Intracranial Frequency Stimulation (DIFS™) technology [1][2] Company Overview - Nexalin develops innovative neurostimulation products aimed at addressing the global mental health epidemic, focusing on non-invasive and undetectable treatments [3] - The company's neurostimulation devices are designed to penetrate deep brain structures associated with mental health disorders, potentially enhancing patient response without adverse side effects [3] - The Nexalin Gen-2 15 milliamp neurostimulation device has received approval in China, Brazil, and Oman, indicating its international market potential [3]